Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 167

1.

Expression of survivin and livin predicts early recurrence in non-muscle invasive bladder cancer.

Xi RC, Sheng YR, Chen WH, Sheng L, Gang JJ, Tong Z, Shan Z, Ying GH, Dong LC.

J Surg Oncol. 2013 Apr;107(5):550-4. doi: 10.1002/jso.23272. Epub 2012 Oct 22.

PMID:
23090902
2.

Livin, Survivin and Caspase 3 as early recurrence markers in non-muscle-invasive bladder cancer.

Wang J, Zhang X, Wei P, Zhang J, Niu Y, Kang N, Zhang Y, Zhang W, Xing N.

World J Urol. 2014 Dec;32(6):1477-84. doi: 10.1007/s00345-014-1246-0. Epub 2014 Mar 5.

PMID:
24595485
3.

[Expression and clinical significance of Survivin and Livin in DukesoB colorectal cancer].

Li JH, He WJ, He YJ.

Ai Zheng. 2007 May;26(5):547-51. Chinese.

PMID:
17672950
4.

Survivin expression in patients with non-muscle-invasive urothelial cell carcinoma of the bladder.

Karam JA, Lotan Y, Ashfaq R, Sagalowsky AI, Shariat SF.

Urology. 2007 Sep;70(3):482-6.

PMID:
17905101
5.
6.

Prognostic value of Survivin and Livin in nasopharyngeal carcinoma.

Xiang Y, Yao H, Wang S, Hong M, He J, Cao S, Min H, Song E, Guo X.

Laryngoscope. 2006 Jan;116(1):126-30.

PMID:
16481824
7.

Livin may serve as a marker for prognosis of bladder cancer relapse and a target of bladder cancer treatment.

Liu HB, Kong CZ, Zeng Y, Liu XK, Bi JB, Jiang YJ, Han S.

Urol Oncol. 2009 May-Jun;27(3):277-83. doi: 10.1016/j.urolonc.2008.03.015. Epub 2008 Jun 16.

PMID:
18555709
8.

Expression and prognostic significance of LIVIN, SURVIVIN and other apoptosis-related genes in the progression of superficial bladder cancer.

Gazzaniga P, Gradilone A, Giuliani L, Gandini O, Silvestri I, Nofroni I, Saccani G, Frati L, Aglianò AM.

Ann Oncol. 2003 Jan;14(1):85-90.

PMID:
12488298
9.

Cathepsin E, maspin, Plk1, and survivin are promising prognostic protein markers for progression in non-muscle invasive bladder cancer.

Fristrup N, Ulhøi BP, Birkenkamp-Demtröder K, Mansilla F, Sanchez-Carbayo M, Segersten U, Malmström PU, Hartmann A, Palou J, Alvarez-Múgica M, Zieger K, Borre M, Ørntoft TF, Dyrskjøt L.

Am J Pathol. 2012 May;180(5):1824-34. doi: 10.1016/j.ajpath.2012.01.023. Epub 2012 Mar 24.

PMID:
22449953
10.

Nuclear expression of survivin is associated with improved survival in metastatic ovarian carcinoma.

Kleinberg L, Flørenes VA, Silins I, Haug K, Trope CG, Nesland JM, Davidson B.

Cancer. 2007 Jan 15;109(2):228-38.

11.

Therapeutic potential of siRNA-mediated combined knockdown of the IAP genes (Livin, XIAP, and Survivin) on human bladder cancer T24 cells.

Yang D, Song X, Zhang J, Ye L, Wang S, Che X, Wang J, Zhang Z, Wang L, Shi W.

Acta Biochim Biophys Sin (Shanghai). 2010 Feb;42(2):137-44.

12.

High nuclear Livin expression is a favourable prognostic indicator in renal cell carcinoma.

Haferkamp A, Bedke J, Vetter C, Pritsch M, Wagener N, Buse S, Crnkovic-Mertens I, Hoppe-Seyler K, Macher-Goeppinger S, Hoppe-Seyler F, Autschbach F, Hohenfellner M.

BJU Int. 2008 Dec;102(11):1700-6. doi: 10.1111/j.1464-410X.2008.07910.x. Epub 2008 Sep 18.

13.

Expression of apoptosis associated proteins Survivin, Livin and Thrombospondin-1 in Burkitt lymphoma.

Kalungi S, Wabinga H, Bostad L.

APMIS. 2013 Mar;121(3):239-45. doi: 10.1111/j.1600-0463.2012.02962.x. Epub 2012 Aug 8.

PMID:
23030305
14.

Ki-67 is an independent indicator in non-muscle invasive bladder cancer (NMIBC); combination of EORTC risk scores and Ki-67 expression could improve the risk stratification of NMIBC.

Ding W, Gou Y, Sun C, Xia G, Wang H, Chen Z, Tan J, Xu K, Qiang D.

Urol Oncol. 2014 Jan;32(1):42.e13-9. doi: 10.1016/j.urolonc.2013.05.004.

PMID:
24360660
15.

Expression of survivin mRNA and livin mRNA in non-small-cell lung cancer.

Tanabe H, Yagihashi A, Tsuji N, Shijubo Y, Abe S, Watanabe N.

Lung Cancer. 2004 Dec;46(3):299-304.

PMID:
15541814
16.

Survivin nuclear labeling index: a superior biomarker in superficial urothelial carcinoma of human urinary bladder.

Yin W, Chen N, Zhang Y, Zeng H, Chen X, He Y, Wang X, Zhou Q.

Mod Pathol. 2006 Nov;19(11):1487-97. Epub 2006 Aug 4.

17.

Survivin, a member of the inhibitors of apoptosis family, is down-regulated in breast carcinoma effusions.

Kleinberg L, Flørenes VA, Nesland JM, Davidson B.

Am J Clin Pathol. 2007 Sep;128(3):389-97.

PMID:
17709312
18.

Expression of cell cycle-associated proteins in non-muscle-invasive bladder cancer: correlation with intravesical recurrence following transurethral resection.

Behnsawy HM, Miyake H, Abdalla MA, Sayed MA, Ahmed Ael-F, Fujisawa M.

Urol Oncol. 2011 Sep-Oct;29(5):495-501. doi: 10.1016/j.urolonc.2009.08.002. Epub 2009 Nov 13.

PMID:
19914103
19.

Livin expression is an independent factor in rectal cancer patients with or without preoperative radiotherapy.

Ding ZY, Zhang H, Adell G, Olsson B, Sun XF.

Radiat Oncol. 2013 Dec 2;8:281. doi: 10.1186/1748-717X-8-281.

20.

[Value of combined detection of urinary Livin and Survivin mRNA expression in the early diagnosis of bladder cancer].

Jiang LL, Xie MM, Wang XR, Zhao Y, Wang ZJ.

Zhonghua Yi Xue Za Zhi. 2013 Nov 26;93(44):3520-2. Chinese.

PMID:
24521893

Supplemental Content

Support Center